Srd5a3tm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Srd5a3tm1d(EUCOMM)Wtsi |
| Name: |
steroid 5 alpha-reductase 3; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:8263020 |
| Gene: |
Srd5a3 Location: Chr5:76288118-76303351 bp, + strand Genetic Position: Chr5, 40.5 cM
|
| Alliance: |
Srd5a3tm1d(EUCOMM)Wtsi page
|
| IMPC: |
Srd5a3 gene page |
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:101977
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutation: |
|
Intragenic deletion
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 76295065 of Chromosome 5 upstream of the critical exon(s) (Build GRCm39). The cassette was composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site was followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted downstream of the targeted exon(s) at position 76298062. The critical exon(s) were thus flanked by loxP sites and crossing to a flp recombinase expressing mouse excised the lacZ sequence and neo selection cassette, leaving loxP sites flanking the critical exon(s). This was then bred to a cre deleter mouse resulting in this null allele.
(J:155845)
|
| Inheritance: |
|
Recessive |
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Original: |
J:101977 The Jackson Laboratory, Information obtained from The Jackson Laboratory, Bar Harbor, ME. Unpublished. 2005-2017; |
| All: |
2 reference(s) |
|